Bionime Corporation

Taiwan Stock Exchange 4737.TW

Bionime Corporation Inventory for the year ending December 31, 2023: USD 16.00 M

Bionime Corporation Inventory is USD 16.00 M for the year ending December 31, 2023, a -8.89% change year over year. Inventory is the value of goods held by a company for sale or used in the production process.

Bionime Corporation Inventory for the year ending December 31, 2022 was USD 17.56 M, a -17.50% change year over year.
Bionime Corporation Inventory for the year ending December 31, 2021 was USD 21.29 M, a 15.14% change year over year.
Bionime Corporation Inventory for the year ending December 31, 2020 was USD 18.49 M, a 39.87% change year over year.
Bionime Corporation Inventory for the year ending December 31, 2019 was USD 13.22 M, a -1.98% change year over year.

Key data

Date	Inventory	Goodwill	Total Assets	Current Liabilities

Taiwan Stock Exchange: 4737.TW

Bionime Corporation

CEO	Mr. Chun-Mu Huang
IPO Date	Dec. 23, 2010
Location	Taiwan
Headquarters	No. 100, Daqing Street
Employees	1,111
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Drugstores & Retail Pharmacies Hardware & Electronics Musical Instruments Personal Care Pharmaceuticals

Description

Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Algeria, Egypt, and internationally. The company offers blood glucose monitors, as well as accessories, such as test strips and lancing devices medical equipment companies, pharmacies, and hospitals. It is also involved in the provision of biotechnology services; examining of pharmaceuticals; and selling of precision instruments. The company was incorporated in 2003 and is based in Taichung, Taiwan.

Key trends

Past 5 years